# A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide

> **NCT05414123** · — · TERMINATED · sponsor: **Biocept, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Leptomeningeal Metastasis
- Leptomeningeal Disease
- Leptomeningeal Neoplasms
- Breast Cancer
- Non-Small Cell Lung Cancer

## Interventions

- **DEVICE:** CNSide

## Key facts

- **NCT ID:** NCT05414123
- **Lead sponsor:** Biocept, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-07
- **Primary completion:** 2023-10-13
- **Final completion:** 2023-10-13
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** The sponsor can no longer financially support the trial.
- **Last updated:** 2023-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414123, "A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05414123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*